Cuu Long Pharmaceutical Joint Stock Company provided earnings guidance for the fiscal year 2022. For the period, the company expects net revenue to be VND 845,510 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29,000 VND | -1.36% |
|
+1.75% | +16.00% |
1st Jan change | Capi. | |
---|---|---|
+16.00% | 84.36M | |
+54.07% | 809B | |
+38.95% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.21% | 238B | |
-0.45% | 221B | |
+14.58% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- DCL Stock
- News Cuu Long Pharmaceutical
- Cuu Long Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2022